Israel Englander’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-191,303
Closed -$69K 7810
2022
Q3
$69K Buy
+191,303
New +$131K ﹤0.01% 6086
2022
Q1
Sell
-47,103
Closed -$54K 8160
2021
Q4
$54K Sell
47,103
-3,085
-6% -$6.28K ﹤0.01% 6461
2021
Q3
$125K Sell
50,188
-201,681
-80% -$559K ﹤0.01% 6340
2021
Q2
$748K Buy
251,869
+233,458
+1,268% +$814K ﹤0.01% 4937
2021
Q1
$65K Buy
+18,411
New +$103K ﹤0.01% 5752
2019
Q2
Sell
-13,089
Closed -$73K 4778
2019
Q1
$73K Buy
+13,089
New +$85K ﹤0.01% 3882

Other funds holding CEMI

Israel Englander's CEMI Position: Q4 2022 in Review

Israel Englander sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2022, closing a stake of 191,303 shares — an estimated $69K sold.

Israel Englander first reported a position in CEMI in Q1 2019 and held it in 6 quarters. The position peaked at $748K in Q2 2021. 38 funds tracked by Wall St. Rank hold CEMI as of Q4 2022.

  • Israel Englander reported no remaining Chembio diagnostics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Israel Englander sold 191,303 Chembio diagnostics, Inc. shares in Q4 2022, an estimated $69K.
  • Israel Englander first reported a position in Chembio diagnostics, Inc. in Q1 2019 and held it in 6 quarters.
  • Israel Englander's Chembio diagnostics, Inc. position peaked at $748K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.